Eric L. Johnson MD North Dakota Diabetes

Eric L. Johnson MD  North Dakota Diabetes Opinions are my own, not my employers
This page is not meant for specific medical advice or treatment

30 years ago, I knew very few people with type 1 diabetes over the age of 60. Now I know quite a few- including me-the q...
12/14/2025

30 years ago, I knew very few people with type 1 diabetes over the age of 60. Now I know quite a few- including me-the question is, who has the expertise to care for us older persons with T1D?

https://www.medscape.com/viewarticle/aging-type-1-diabetes-success-story-brings-challenges-2025a1000yrd?src=mbl_msp_iphone&ref=text&ecd=WNL_trdalrt_pos1_251213_etid7954051&uac=82241SY&impID=7954051rbeto

As people with type 1 diabetes live longer than ever before, both clinicians and patients are recognizing the need to prepare for the challenges that accompany aging with this condition.

https://www.facebook.com/share/p/1BYqm4D4Rc/?mibextid=wwXIfr
12/10/2025

https://www.facebook.com/share/p/1BYqm4D4Rc/?mibextid=wwXIfr

Today in 1923, the Nobel Prize in Physiology or Medicine was awarded to Sir Frederick Banting and John Macleod for the discovery of insulin. 💙💉 You can continue to honor their legacy—become a Diabetes Advocate at diabetes.org/Advocacy.

The 2026 ADA Standards of Care have been released this morning
12/08/2025

The 2026 ADA Standards of Care have been released this morning

Discover the latest ADA diabetes management guidelines, including current diabetes guidelines, clinical practice recommendations, and treatment guidelines for diabetes mellitus to support quality care.

I’ve had type  1 diabetes for 36 years, and although things haven’t always gone my way, I’ve seen amazing advances https...
11/14/2025

I’ve had type 1 diabetes for 36 years, and although things haven’t always gone my way, I’ve seen amazing advances

https://www.facebook.com/share/p/184jBfFaq3/?mibextid=wwXIfr

Today, we recognize during and celebrate the strength and resilience of everyone affected by diabetes. 🌎 💙 With 589 million adults worldwide living with diabetes, our fight has never been more important. Find tools, tips, and resources to support your journey and your loved ones at diabetes.org.

What was the problem here? It’s common and I hear it a lot.
11/06/2025

What was the problem here? It’s common and I hear it a lot.

November is Diabetes Awareness Month. I’ve had Type 1 diabetes for 36 years and it was a life changing diagnosis.  Thank...
11/04/2025

November is Diabetes Awareness Month. I’ve had Type 1 diabetes for 36 years and it was a life changing diagnosis. Thanks to family, friends, and colleagues who have supported me along the way.

https://www.facebook.com/share/p/1BEzDbWRgP/?mibextid=wwXIfr

Join the fight to end diabetes and help spread awareness this with our free toolkit available at bit.ly/4ogc27c.

Show your support—drop a 💙 below if you’re joining us in the fight to end diabetes!

Closed loop insulin delivery superior to standard care in pregnant patients with type 1 diabetes
10/24/2025

Closed loop insulin delivery superior to standard care in pregnant patients with type 1 diabetes

This randomized clinical trial assesses the effect of a closed-loop insulin system on time spent in the pregnancy-specific glucose range among pregnant women with type 1 diabetes.

Official announcement of ADA’s new journal, coming Feb 2026. I serve on the editorial board
09/30/2025

Official announcement of ADA’s new journal, coming Feb 2026. I serve on the editorial board

Introducing DOC CARE | Journals Gateway | American Diabetes Association Introducing: Diabetes, Obesity, and Cardiometabolic CARE A New Journal for the Interdisciplinary Health Care Team In early 2026, the American Diabetes Association (ADA) will launch a new journal designed for primary care clinici...

09/22/2025

I’m currently working on 2 textbook chapters for the Association of Diabetes Care and Education
Specialists- one on neuropathy, one on retinopathy and other diabetes eye diseases. Publication will be in 2026.

Orforglipron tops semaglutide in head to head trial
09/18/2025

Orforglipron tops semaglutide in head to head trial

The ACHIEVE-3 trial was a 52-week, randomized, open-label study that included 1698 T2D patients inadequately controlled on metformin.

New oral GLP-1 performs well in recent trial
08/26/2025

New oral GLP-1 performs well in recent trial

The ATTAIN-2 trial evaluated the efficacy and safety of orforglipron in adults with a BMI of greater than or equal to 27kg/m2 and type 2 diabetes.

Address

Grand Forks, ND
58201

Opening Hours

Monday 9am - 5pm
Tuesday 8am - 12pm
1pm - 2pm
Wednesday 8am - 12pm
1pm - 2pm
Thursday 8am - 12pm
Friday 8am - 12pm
1pm - 2pm

Alerts

Be the first to know and let us send you an email when Eric L. Johnson MD North Dakota Diabetes posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category